myeong seong sim

myeong seong sim


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
HKHye Jeong Kim
Hye Jeong Kim
MSmyeong seong sim
myeong seong sim
DLDong Hyun Lee
Dong Hyun Lee
CKChun Kim
Chun Kim
YCYoungwoo Choi
Youngwoo Choi
ICIl Yup Chung
Il Yup Chung

Verified
Journal Article
Open access
PDF file
MSmyeong seong sim
myeong seong sim
HKHyeJeong Kim
HyeJeong Kim
SJSangHee Jo
SangHee Jo
CKChun Kim
Chun Kim
ICIl Yup Chung
Il Yup Chung
Lysophosphatidylserine (LysoPS) is an amphipathic lysophospholipid that mediates a broad spectrum of inflammatory responses through a poorly characterized mechanism. Because LysoPS levels can rise in a variety of pathological conditions, we sought to investigate LysoPS’s potential role in airway epithelial cells that actively participate in lung homeostasis. Here, we report a previously unappreciated function of LysoPS in production of a mucin component, MUC5AC, in the airway epithelial cells. LysoPS stimulated lung epithelial cells to produce MUC5AC via signaling pathways involving TACE, EGFR, and ERK. Specifically, LysoPS- dependent biphasic activation of ERK resulted in TGF-α secretion and strong EGFR phosphorylation leading to MUC5AC production. Collectively, LysoPS induces the expression of MUC5AC via a feedback loop composed of proligand synthesis and its proteolysis by TACE and following autocrine EGFR activation. To our surprise, we were not able to find a role of GPCRs and TLR2, known LyoPS receptors in LysoPS-induced MUC5AC production in airway epithelial cells, suggesting a potential receptor-independent action of LysoPS during inflammation. This study provides new insight into the potential function and mechanism of LysoPS as an emerging lipid mediator in airway inflammation.

1 January 2026 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
SJSangHee Jo
SangHee Jo
IBIkhyeon Bae
Ikhyeon Bae
MSmyeong seong sim
myeong seong sim
HKHye Jeong Kim
Hye Jeong Kim
CKChun Kim
Chun Kim
HCHun Soo Chang
Hun Soo Chang
Jo SH, et al. Allergy Asthma Immunol Res. 2026 Mar;18(2):204-223. https://doi.org/10.4168/aair.2026.18.2.204

1 May 2023 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SJSang Hee Jo
Sang Hee Jo
IBIkhyeon Bae
Ikhyeon Bae
MSmyeong seong sim
myeong seong sim
HKHye Jeong Kim
Hye Jeong Kim
CKChun Kim
Chun Kim
ICIl Yup Chung
Il Yup Chung
Secreted airway mucins form a mucous gel consisting of MUC5AC and MUC5B and maintain airway homeostasis for appropriate mucociliary clearance and airway defense. There is conceivably a global mechanism to counteract excessive mucin production in response to incessant exposure to external and internal stimuli, which otherwise leads to goblet metaplasia and mucus hyperproduction. Here, we report that butyrate, a short-chain fatty acid (SCFA), strongly suppresses MUC5AC production at as low as sub-to micromolar concentrations in NCI-H292, airway epithelial cells. Butyrate transcriptionally inhibits MUC5AC mRNA and protein that are induced by a variety of stimuli including EGF and LPS. In line, butyrate upregulates FOXA2, which is known to block goblet cell metaplasia. The mode of the inhibition by butyrate appears to be independent of the known receptors of butyrate. In addition, butyrate does not alter the EGFR signaling pathway. Chromatin immunoprecipitation analysis demonstrates that histone H3K27 acetylation level is increased upon stimulation with EGF and returns to baseline in the presence of butyrate. We propose that butyrate, a metabolic product of gut microbiota, plays a central role in maintaining homeostasis of airway mucous gel by counteracting mucin production resulting from repeated provocation of airway epithelium. National Research Foundation of Korea (NRF) funded by the Korean government (MSIT), NRF-2022R1A2B5B01002127.